Finding sustainable paths to improved patient outcomes
Sustainability in action
We believe our collective health depends on the health of our planet. That makes environmental responsibility an essential complement to our core mission: advancing patient care through innovation and technology.



What does responsible end‑of‑life management look like for Medtronic products?
Patients inspire our pursuit of innovation — and our mission drives us to put inspiration into action. That’s why we’re taking steps to elevate outcomes for patients, customers, and the environment.
Our trusted vessel sealing technology delivers reliable performance along with sustainability.
By removing the black plastic wrap on the shaft of our LigaSure™ blunt tip and Maryland jaw devices, we are able to:
Refer to the IFU for more information on Indications, Contraindictions and Risks.
Experience the freedom of a cordless design while leveraging reusable components to reduce waste.
The latest generation of the GI Genius™intelligent endoscopy system offers:
Proven technology with meaningful impact:7-9
With GI Genius™ CADx, endoscopists can apply cost-saving strategies with confidence.7
This device is not intended to replace clinical decision making. Refer to the IFU for more information on Indications, Contraindictions and Risks.
BIS™ technology individualizes dosing from beginning to end, helping you make efficient use of OR resources.10–14
By reflecting the anesthetic effect on each patient’s brain to personalize dosing, the BIS™ brain monitoring system can:
The BIS™ brain monitoring system should not be used as the sole basis for diagnosis or therapy and is intended only as an adjunct in patient assessment. Reliance on the BIS™ brain monitoring system alone for intraoperative anesthetic management is not recommended.
We’re exploring ways to extend product life by keeping materials and components efficiently circulating within the economy through forward-thinking product design and end-of-life solutions.
The modular design of the intelligent Signia™ stapling system advances material efficiency in linear and circular powered stapling while upholding the highest standards of quality.
Risks may include, but are not limited to: acute/chronic pain, bleeding, infection, and tissue damage. Potential complications may include failure to anastomose, blood loss, ischemia, stenosis, bowel perforation, gastro-intestinal obstruction/occlusion, and tissue breakdown.
The TruClear™ system enables effective procedures#,18–20 while advancing environmentally responsible practices.
Reusable components like the TruClear™ handpiece reduce the need for frequent production and disposal and allow for reduced packaging.
By leveraging the TruClear™ system and HysteroLux™ fluid management you can reduce waste by:
As with all operative hysteroscopy, adverse effects include but are not limited to intravasation, uterine perforation, exposure to body fluids, laceration, carcinogen exposure, electric shock, and air embolism.
When sensors are repositioned, they lose their stickiness. The adhesive can stick to itself, or the sensor may struggle to re-post a number. Taping over the sensor is sometimes attempted, but repositioning often leads to early disposal.
To address this challenge, Medtronic has introduced an SpO2 sensor with a silicone adhesive designed to withstand up to 18 repositions without losing its adhesiveness.*
By enabling multiple repositions, the sensor can remain in use longer instead of being discarded prematurely.
The McGRATH™ rechargeable battery system powers the McGRATH™ video laryngoscope to support higher first-pass success rates24,25 lowering the environmental impact of intubation.
Minimalist material use:
For trained personnel only. For specific indications and instructions for use, please refer to the product manual.
We’re committed to developing initiatives meant to minimize customer waste, reduce materials of concern, and shrink the environmental footprint of operations globally.
Medtronic will eliminate 2,500 tons of paper waste by FY30 by moving to eIFUs.
Hugo™ RAS system: Risks may include arrythmia, bleeding, burns, infection, tissue damage, or other complications.
We’ve removed the electric clip counter and lithium battery from Endo Clip™ III devices, instead color-coding the last three clips in the device blue to alert surgeons of low clip count to reduce waste without compromising quality.
This small design change allows us to:
Refer to the IFU for more information on Indications, Contraindictions and Risks.
Our universal trocar platform provides versatility and efficiency34 in one complete solution.
The redesigned packaging configuration on VersaOne™ trocars is made from recycled materials††,35 and results in an 80% reduction in packaging material weight due to the redesigned soft pouch display packaging††,35
Managing end-of-life responsibly at Medtronic
The waste impact of medical devices creates a sustainability challenge for healthcare.
Medtronic is
investing in waste reduction through extended product life and end-of-life solutions.1



Circularity across the portfolio
Innovative offerings that pair the right solutions with the right products
* Based on head-to-head testing with MaxN – CSR 2021 0312v1 S20-12
† Trust in LigaSure™ technology is rooted in its globally documented reliable performance.
‡ 25 out of 27 surgeons surveyed after use agreed. 26 out of 27 surgeons surveyed after use agreed. Compared to the Sonicision™ curved jaw device.
§ Mass comparison made with dissector and assembly tool.
◊ Total waste based on device component weights and expected circulation ratio of each component per procedure.
¶ Total waste based on device component weights and expected circulation ratio of each component on a per-procedure basis comparing CDH31P to the Signia™ circular stapler with a 31 mm Tri-Staple™ reload (n = 3, p < 0.001).
# Five cohort studies (n=339) reported IUAs in 22.4% (95% confidence interval, 18.3%–27%) of women hysteroscopically evaluated. Significantly more IUAs were encountered after dilation and curettage (D&C) compared with after hysteroscopic resection (HR): 30% vs. 13%. Incomplete evacuation was encountered in, respectively, 29% and 1% of the D&C and HR cases.
∆ Based on a standardized operation runtime of 10,000 minutes, disposing the McGRATH™ rechargeable battery generate 24.72 grams of waste, while disposing the McGRATH™ disposable batteries generate 1098.5 grams of waste.
∞ Based on in vivo, ex vivo, and benchtop testing. Preclinical results may not correlate with clinical performance in humans. Bench test results may not necessarily be indicative of clinical performance.
†† Based on an analysis of the environmental impact of trocar packaging configurations.
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.